There is no excerpt because this is a protected post.
Read moreWe're delighted to announce our participation at ISPOR Europe 2024 in Barcelona this November. We'll...
Read moreWe examine whether the joint clinical assessment will expedite patient access and influence value pe...
Read moreOur latest article discusses key strategies for pharma manufacturers' commercial readiness for EU HT...
Read moreThe collaboration is aimed at enhancing HTA reports, facilitating resource and knowledge sharing and...
Read moreWe summarise the key discussions from HTAi 2024, with a focus on sustainability, networks and innova...
Read moreWe discuss the updates on EU HTA from the June meeting of the Member State Coordination Group on Hea...
Read moreLearn how to navigate the upcoming EU HTA regulation and optimise market access strategies for oncol...
Read moreOur experts analyse how local European markets are integrating the EU HTA outputs into national proc...
Read moreConsultation launched on EU draft Regulation for joint clinical assessments, seeking feedback to imp...
Read more